Riboxx siRNA and miRNA mimics: YOUR Gene silencing BONUS...
Riboxx PHARMACEUTICALS has invented the RNAi-cap™ Technology for siRNA and miRNA mimics dedicated to RNAi-Drug development.
The RNAi-cap™ Technology increases knock-down potency, reduces off-target effects and toxicity, and improves stabiliy with subsequent longer gene silencing .
Riboxx is proud to offer the RNAi-cap™ Technology to scientists as a BONUS to their gene silencing experiments.
YOUR gene silencing BONUS is available as:
• iBONi® siRNA and iBONi® siRNA Controls
• iVORi® siRNA in VIVO
• CONmiR® miRNA mimics and CONmiR® Controls
• CONmiR® miRNA mimic in VIVO
Riboxx® siRNA and miRNA mimics meet scientists requirements on
• Potency, as shown in numerous scientific publications
• Fast delivery, usually within 10 days (in EU)
• Price: Riboxx offers you a PRICE BONUS as well !
Latest Publications using the RNAi-cap™ Technology
 Nolte et al. N Biotechnol. 2013 Jan 25;30(2):159-65. > to the products
 Tattikota et al. Mol Cell Proteomics. 2013 Jan 28. > to the products
 Chen et al. Chemistry & Biology. 2012 Nov 21;19(11):1423-1436. > to the products
 Colecchia et al. Autophagy. 2012 Dec; 8(12):1724–1740. > to the products
 Brambillasca et al. J Biol Chem. 2012 Dec. 287(50):41808–41819. > to the products